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Abstract
Background: Unicuspid unicommissural aortic valve is an extremely rare congenital anomaly that usually presents
in adulthood but can rarely present in infancy. We report a 17-year-old patient with congenital aortic stenosis
secondary to unicuspid unicommissural aortic valve that was successfully treated with aortic valve replacement.
Case presentation: The patient was diagnosed with aortic stenosis after a murmur was heard in the newborn nursery
and subsequently underwent aortic balloon valvuloplasty 6 weeks after birth. He had been regularly followed up since
and underwent numerous cardiac catheterizations, including another aortic balloon valvuloplasty at age 13. During
follow-up at age 17, the patient presented with symptomatic severe aortic stenosis and mild left ventricular hypertrophy.
Aortic valve replacement was planned since the patient was nearly adult-sized and to reduce the risk of
cardiac decompensation. During the operation an unicuspid unicommissural aortic valve was revealed. The
patient recovered well post-operatively. He was discharged 5 days after the surgery in good condition and
was completely symptom-free at follow-up 6 weeks later.
Conclusions: Unicuspid aortic valve is a rare congenital anomaly that can cause congenital aortic stenosis. It
is seldom diagnosed pre-operatively but should be suspected in infants presenting with aortic stenosis.
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Background
Unicuspid aortic valve (UAV) is an extremely rare con-
genital malformation with an estimated prevalence of
0.02% in adults [1]. UAVs share many characteristics
with bicuspid valves, such as premature valvular calcifi-
cations, aortic root dilations, and aortic dissection [2]. In
unicuspid valves, these changes occur even more rapidly.
UAVs most often present with aortic stenosis, either
isolated or with concomitant aortic regurgitation [2, 3].
UAVs are divided into two subtypes; unicommissural
and acommissural UAVs. Since acommissural UAVs have
smaller aortic orifice compared to unicommissural valves,
they have a more aggressive presentation and are usually
symptomatic at birth [3]. Unicommissural UAVs generally
present in the 4th to 6th decade of life [2, 4], but can
rarely present at infancy [5]. We report a case of
17-year-old male with congenital aortic stenosis secondary
to a unicommissural UAV that was successfully treated
with aortic valve replacement (AVR).
Case report
A 17-year-old male with congenital aortic stenosis pre-
sented to his pediatric cardiologist for follow-up. He had
been diagnosed with aortic stenosis after a murmur was
heard in the newborn nursery, and subsequently under-
went aortic balloon valvuloplasty 6 weeks after birth. He
had been regularly followed up since and underwent nu-
merous cardiac catheterizations, including another aortic
balloon valvuloplasty at age 13.
Upon presentation, echocardiography was performed
and revealed a mean gradient of 54 mmHg, maximum
gradient of 119 mmHg through the aortic valve orifice,
aortic valve area of 0.4 cm2/m2, and septal diameter of
1.6 cm2 (Fig. 1). Subsequently, the patient was scheduled
for AVR 3 weeks later. A CT angiography was obtained
before surgery and revealed a mild ascending aortic dila-
tion of 34.4 × 42.2 mm in maximal diameter, without
increased annular size (Fig. 2).
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During pre-operative examination, the patient admitted
having dyspnea during exertion but had never experienced
angina, palpations, or syncope. He reported being very
physically active. A 4/6 crescendo/decrescendo systolic
murmur was auscultated over the whole precordium, with
the murmur radiating to the neck. Lung auscultation was
clear and jugular venous distension was absent. His chest
X-ray was normal with cardiac index within referral range.
The patient and his parents expressed their desire for
biologic valve implantation.
AVR was performed under normothermic cardiopul-
monary bypass. Following aortotomy an unicuspid
unicommissural aortic valve was revealed, with a
single commissure located just right of the left coron-
ary ostium. The valve was thickened and extremely
stenotic with mild calcification underneath the right
coronary ostium (Fig. 3). The valve was removed in
one piece using scissors and knife, and replaced with
a 27 mm biologic Freestyle valve (Medtronic Inc.,
Minneapolis, Minnesota) using continuous 4–0
Prolene sutures. The stentless valve was implanted
subcoronally to allow for a nonobstructive position
for the right and left coronary ostia between the com-
missures of the newly implanted bioprosthesis. Finally,
the ascending aorta was closed using continuous 4–0
Prolene sutures.
Fig. 1 a Echocardiography demonstrating an increased septal diameter (arrow). b Echocardiography measurements demonstrating a mean
gradient of 54 mmHg, maximal gradient of 119 mmHg, and peak flow of 5.5 m/s through the aortic valve orifice
Fig. 2 a Lateral and b anterior projection of a three-dimensional reconstructed CT angiography demonstrating a slightly dilated ascending aorta
and normal sized aortic annulus
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Post-operatively, there were no adverse events and the
patient recovered well. He was discharged 5 days after
surgery in good condition. At follow up 6 weeks later,
the patient had returned to his daily activities and was
completely symptom-free. An echocardiography revealed
a functional valve with no regurgitation and insignificant
gradient across the valve. The left ventricular hyper-
trophy was receding with a measured septal diameter of
1.2–1.4 mm. Left ventricular function was considered
normal and no pericardial effusion was noted.
Discussion and conclusions
UAV is a rare cause of aortic stenosis. Unicommissural
UAVs are usually asymptomatic early in life, although they
can rarely present at infancy, as in the previously described
case. In a case series of 21 patients with unicommissural
UAV, only 2 patients presented during the first year of life
[5]. Even though the patient was diagnosed with aortic
stenosis shortly after birth, the diagnosis of UAV was not
made until open heart surgery was performed 17 years
later. This is common, indeed the majority of UAVs are di-
agnosed peri-operatively [2, 6]. Transesophageal echocardi-
ography (TEE) is the gold standard for diagnosis of UAV
with a sensitivity and specificity of 75 and 86% respectively
[7]. With evolving imaging technology, such as
three-dimensional TEE, a higher frequency of
pre-operative diagnosis is anticipated.
Congenital aortic stenosis due to UAV is most often
treated with balloon valvuloplasty, surgical valvotomy, or
commissurotomy [3]. AVR is generally not recommended
until the patient has reached full size. This is due to higher
mortality rates compared to adults as well as higher fre-
quency of re-operation due to patient-prosthesis mismatch
and structural valve degeneration [8]. If AVR is needed in
infancy or early childhood, a Ross surgery is often recom-
mended [9, 10]. In a Ross procedure, the aortic valve is
replaced with the patient’s own pulmonary valve. The auto-
graft has some capacity to grow along with the patient’s
heart thereby reducing the risk of patient-prosthesis
mismatch in a growing child. The main problem with the
Ross procedure is that a simultaneous pulmonary valve
replacement is required, thus converting a single valve
disease into a double valve pathology [11]. The Ross pro-
cedure is more technically difficult than other valve
replacement alternatives, with relatively high mortality, but
has been shown to be safe in experienced hands [8].
When the patient presented pre-operatively, he had
symptomatic severe aortic stenosis and mild left ventricular
hypertrophy. AVR was planned since the patient was nearly
adult-sized and to reduce the risk of cardiac decompensa-
tion due to further cardiac hypertrophy. In preparation for
the AVR, the patient and his guardians expressed their
desire for bioprosthetic valve replacement. Although mech-
anical valves have generally been recommended for patients
younger than 60 years old, multiple factors have led to
increased use of bioprosthetic valves in younger popula-
tions, including high re-operative survival rate, lifestyle
expectations, and recent advances in transcatheter valve
replacements. AHA/ACC guidelines for managing valvular
heart diseases state that the choice of prosthetic valve type
should be a shared decision and bioprosthetic valves should
be recommended if anticoagulation is not desired [12]. Life-
long anticoagulation following mechanical valve replace-
ment can be debilitating for physically active individuals
and reduce quality of life. Additionally, the annual risk of
major bleeding is about 3% for oral anticoagulants [13, 14]
but has been reported as high as 4.4% following mechanical
valve replacement [15]. The benefit of lower re-operative
rates in mechanical valve replacements must be carefully
weighed to the risk of bleeding complications and reduc-
tion in quality of life on a case-by-case basis.
In conclusion, UAV is a rare cause of aortic stenosis,
but should be suspected in infants presenting with aortic
stenosis. Although rarely diagnosed pre-operatively, TEE
has relatively high sensitivity and specificity for the con-
dition. AVR is generally not recommended until patients
have reached full-size due to higher mortality and
re-operation rates compared to adults. Instead, balloon
Fig. 3 a The aortic valve revealed during surgery. b Macroscopic view of the resected unicommissural unicuspid aortic valve
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valvuloplasty, surgical valvotomy, or commissurotomy
are the initial treatments of choice.
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